BrightSpring Health Services, Inc. (BTSG) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
BrightSpring Health Services, Inc. (BTSG) trades at $59.33 with AI Score 83/100 (Grade A+). BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. Market cap: $11.6B, Sector: Healthcare.
Price as of Aug 20, 2026 · Last analyzed: May 4, 2026BTSG stock analysis for 2026: Analysts have set a consensus price target of $44.47 for BrightSpring Health Services, Inc., suggesting 25.1% downside from the current price of $59.33. The AI MoonshotScore is 83/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
BTSG: the 3 scored disciplines are evenly split. Dominant signal: Growth Durability strong.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
BrightSpring Health Services, Inc. (BTSG) Healthcare & Pipeline Overview
BrightSpring Health Services, Inc. delivers home and community-based healthcare services in the U.S., focusing on pharmacy and provider solutions for Medicare, Medicaid, and insured individuals. With a platform built on clinical and supportive care, BrightSpring serves patients through its network of clinical providers and pharmacists, distinguishing itself in the healthcare information services sector.
What Is the Investment Thesis for BTSG?
BrightSpring Health Services, Inc. presents a compelling investment case centered on its position in the growing home and community-based healthcare market. With a market capitalization of $11.6B and a P/E ratio of 90.1, the company demonstrates significant investor interest. Key value drivers include the increasing demand for in-home healthcare services, driven by an aging population and a preference for personalized care. BrightSpring's focus on Medicare and Medicaid populations offers a stable revenue stream, while its integrated pharmacy and provider services create synergistic growth opportunities. The company's 2.3% profit margin and 12.2% gross margin indicate areas for potential improvement through operational efficiencies. A potential risk factor is the company's beta of 2.05, indicating higher volatility compared to the market. Overall, BrightSpring's growth trajectory is tied to its ability to capitalize on market trends and manage operational performance.
Based on FMP financials and quantitative analysis
BTSG Key Highlights
Market Cap of $11.6B indicates substantial investor confidence in BrightSpring's market position.
- P/E Ratio of 90.1 reflects investor expectations of future earnings growth.
- Profit Margin of 2.3% suggests opportunities for improvement through operational efficiencies.
- Gross Margin of 12.2% indicates the profitability of BrightSpring's core services.
- Beta of 2.05 suggests higher volatility compared to the market, potentially due to growth-oriented investments.
Who Are BTSG's Competitors?
BTSG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| KRYS Krystal Biotech, Inc. | $343.34 | +3.16% | $10.1B | 99 |
| HQY HealthEquity, Inc. | $103.95 | +1.13% | $8.69B | 90 |
| BRKR Bruker Corporation | $58.65 | +3.15% | $8.93B | 58 |
| CHE Chemed Corporation | $535.70 | +1.22% | $7.00B | 83 |
| CRSP CRISPR Therapeutics AG | $58.90 | -1.52% | $5.68B | 44 |
| BTSGU BrightSpring Health Services, Inc. Tangible Equity Unit | $195.62 | -0.45% | $11.5B | 81 |
| PMCUF Pro Medicus Limited | $137.82 | +3.16% | $14.4B | 59 |
| HNGE Hinge Health, Inc. | $88.46 | +0.25% | $6.85B | 95 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BTSG's Key Strengths?
Integrated home and community-based care model.
- Strong relationships with payers and providers.
- Experienced management team.
- Focus on high-growth markets.
What Are BTSG's Weaknesses?
Relatively low profit margin.
- High beta indicating higher volatility.
- Dependence on government funding.
- Exposure to regulatory changes.
What Could Drive BTSG Stock Higher?
Expansion of telehealth services to improve access to care.
- Strategic acquisitions and partnerships to expand service offerings.
- Focus on value-based care models to improve patient outcomes and reduce costs.
- Potential expansion into new geographic markets.
- Development of specialized care programs for specific patient populations.
What Are the Key Risks for BTSG?
Rich valuation — a P/E of 90.1 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Insider selling — insiders were net sellers of roughly $1.7B recently.
- Increased competition in the healthcare industry.
- Changes in government regulations impacting reimbursement rates.
- Economic downturn affecting patient access to healthcare services.
- Cybersecurity risks compromising patient data.
- Dependence on government funding for Medicare and Medicaid programs.
What Are the Growth Opportunities for BTSG?
- Expansion of Telehealth Services: BrightSpring has the opportunity to expand its telehealth services to reach a broader patient base and improve access to care. The telehealth market is projected to reach $55.6 billion by 2027, growing at a CAGR of 23.5% from 2020 to 2027. By leveraging technology, BrightSpring can enhance its service offerings and improve patient outcomes, particularly in rural and underserved areas. This expansion can be achieved through strategic partnerships with telehealth providers and investments in digital health infrastructure.
- Strategic Acquisitions and Partnerships: BrightSpring can pursue strategic acquisitions and partnerships to expand its service offerings and geographic reach. The healthcare industry is consolidating, creating opportunities for BrightSpring to acquire complementary businesses and integrate them into its platform. By partnering with other healthcare providers, BrightSpring can enhance its capabilities and offer a more comprehensive suite of services to its patients. These strategic moves can drive revenue growth and increase market share.
- Focus on Value-Based Care Models: BrightSpring can capitalize on the shift towards value-based care models by demonstrating its ability to improve patient outcomes and reduce healthcare costs. Value-based care models reward providers for delivering high-quality, cost-effective care. By focusing on preventive care and chronic disease management, BrightSpring can help patients stay healthy and avoid costly hospitalizations. This approach can attract payers and patients, driving revenue growth and improving profitability.
- Expansion into New Geographic Markets: BrightSpring has the opportunity to expand its services into new geographic markets, both domestically and internationally. The demand for home and community-based healthcare services is growing globally, creating opportunities for BrightSpring to replicate its successful business model in new regions. By conducting market research and identifying areas with unmet healthcare needs, BrightSpring can strategically expand its footprint and increase its revenue base.
- Development of Specialized Care Programs: BrightSpring can develop specialized care programs for specific patient populations, such as those with chronic diseases or disabilities. By focusing on specific healthcare needs, BrightSpring can differentiate itself from competitors and attract patients seeking specialized care. These programs can be tailored to meet the unique needs of each patient population, improving outcomes and enhancing patient satisfaction. This targeted approach can drive revenue growth and strengthen BrightSpring's market position.
What Are BTSG's Competitive Advantages?
- Established network of clinical providers and pharmacists.
- Strong relationships with Medicare and Medicaid agencies.
- Integrated platform for delivering pharmacy and provider services.
- Focus on home and community-based care.
What Does BTSG Do?
Founded in 1974 and headquartered in Louisville, Kentucky, BrightSpring Health Services, Inc. has evolved into a significant player in the home and community-based healthcare services industry. Originally known as Phoenix Parent Holdings Inc., the company rebranded to BrightSpring Health Services, Inc. in May 2021, marking a renewed focus on its core mission. BrightSpring operates a comprehensive platform that delivers a range of pharmacy and provider services, emphasizing clinical and supportive care within home and community settings. These services cater to a diverse patient base, including those covered by Medicare, Medicaid, and private insurance plans. The company's integrated approach involves a network of clinical providers and pharmacists who work collaboratively to deliver personalized care solutions. BrightSpring's commitment to innovation and patient-centered care has positioned it as a key provider in the evolving healthcare landscape, addressing the growing demand for accessible and convenient healthcare options. With 37,000 employees, BrightSpring has a substantial reach and impact on the healthcare sector.
What Products and Services Does BTSG Offer?
- Operates a home and community-based healthcare services platform.
- Delivers pharmacy services to patients in home settings.
- Provides clinical care through a network of healthcare providers.
- Offers supportive care services to individuals with disabilities and chronic illnesses.
- Serves Medicare, Medicaid, and insured populations.
- Focuses on delivering care in home and community settings.
How Does BTSG Make Money?
- Generates revenue through pharmacy services provided to patients.
- Earns fees for clinical and supportive care services.
- Contracts with Medicare, Medicaid, and private insurance companies.
- Focuses on delivering cost-effective care in home and community settings.
What Industry Does BTSG Operate In?
BrightSpring Health Services, Inc. operates within the rapidly expanding healthcare information services industry. The industry is driven by factors such as an aging population, increasing chronic diseases, and technological advancements. The market is competitive, with key players including KRYS: Krystal Biotech, Inc., HQY: HealthEquity, Inc., BRKR: Bruker Corporation, CHE: Chemed Corporation, and CRSP: CRISPR Therapeutics AG. BrightSpring differentiates itself through its integrated home and community-based care model, focusing on pharmacy and provider services. The industry is experiencing growth due to the shift towards value-based care and the increasing adoption of telehealth and remote patient monitoring technologies.
Who Are BTSG's Key Customers?
- Individuals covered by Medicare.
- Individuals covered by Medicaid.
- Individuals with private insurance plans.
- Individuals with disabilities and chronic illnesses.
Insider Activity
Over the past six months, BrightSpring Health Services, Inc. insiders filed 29 SEC Form 4 transactions — 19 sales and 10 purchases. On net that is roughly 30.4M shares disposed (about $1.7B), a signal worth weighing alongside the fundamentals.
Forward Outlook
Wall Street analysts project BrightSpring Health Services, Inc. revenue of about $15.30B for fiscal 2026, with EPS near $1.80. The estimate reflects 12 contributing analysts.
Financial Health
BrightSpring Health Services, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.64 places it in the safe zone, indicating low near-term bankruptcy risk.
Key Financial Metrics
Return on equity for BrightSpring Health Services, Inc. stands at 16.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.0%, showing how much profit it generates from its asset base. BTSG trades at a trailing price-to-earnings ratio of 90.09, above the Healthcare sector average of ~23x. Its free cash flow yield is 3.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.74 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.2%, the inverse of the P/E and a quick read on earnings relative to price.
BrightSpring Health Services, Inc. (BTSG) Valuation Context
Valued at $11.6B, BTSG is classified as a large-cap stock. Relative to its peer group, BTSG's quantitative score of 83/100 is roughly in line with the peer average of 75/100.
BTSG Revenue & Earnings Trend
In Q2 2026, BTSG generated $3.87B in top-line revenue, marking a sequential increase of 7.2%. The company recorded net income of $86.7M, with diluted EPS of $0.39. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Healthcare company. Across the four most recent quarters, BTSG averaged $0.34 in diluted EPS.
Company Profile
BrightSpring Health Services, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Louisville, US. The company is led by CEO Jon Rousseau. BTSG has traded publicly since 2024.
BTSG Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Integrated home and community-based care model.
- Strong relationships with payers and providers.
- Experienced management team.
- Focus on high-growth markets.
Bear Case
- Relatively low profit margin.
- High beta indicating higher volatility.
- Dependence on government funding.
- Exposure to regulatory changes.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $3.87B | $87M | $0.39 |
| Q1 2026 | $3.61B | $74M | $0.34 |
| Q4 2025 | $3.55B | $77M | $0.35 |
| Q3 2025 | $3.33B | $56M | $0.26 |
Based on FMP financials and quantitative analysis
BTSG Latest News
-
BTSG: Lowering target price to $80.00
Argus Research · Jul 29, 2026
-
2 Reasons to Like BTSG (and 1 Not So Much)
Yahoo! Finance: BTSG News · Jul 24, 2026
-
BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy?
zacks.com · Jul 24, 2026
-
3 Market-Beating Stocks to Target This Week
Yahoo! Finance: BTSG News · Jul 24, 2026
BTSG Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BTSG.
Price Targets
Consensus target: $44.47
BTSG MoonshotScore
What does this score mean?
The MoonshotScore rates BTSG 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Latest News
BTSG: Lowering target price to $80.00
2 Reasons to Like BTSG (and 1 Not So Much)
BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy?
3 Market-Beating Stocks to Target This Week
Leadership: Jon Rousseau
CEO
Jon Rousseau serves as the CEO of BrightSpring Health Services, Inc., leading a workforce of 37,000 employees. His career spans various leadership roles within the healthcare industry, demonstrating a deep understanding of healthcare operations and strategy. Rousseau's expertise includes healthcare management, business development, and financial performance. His educational background includes advanced studies in business administration and healthcare management, providing him with a strong foundation for leading a complex healthcare organization. Prior to joining BrightSpring, Rousseau held executive positions at other healthcare companies, where he focused on improving patient care and driving business growth.
Track Record: Under Jon Rousseau's leadership, BrightSpring Health Services, Inc. has focused on expanding its home and community-based healthcare services platform. He has overseen the company's strategic initiatives to enhance its service offerings and improve patient outcomes. Rousseau has also focused on strengthening BrightSpring's relationships with payers and providers. His leadership has been instrumental in driving the company's growth and solidifying its position as a key player in the healthcare industry.
Common Questions About BTSG (Healthcare)
What does the AI Score mean for BTSG?
BTSG holds an AI Score of 83/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. They deliver pharmacy and provider services, including clinical …
What does BrightSpring Health Services, Inc. Common Stock do?
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company focuses on delivering pharmacy and provider services, including clinical and supportive care, to Medicare, Medicaid, and insured populations.
What do analysts say about BTSG stock?
Analyst coverage of BrightSpring Health Services, Inc. Common Stock (BTSG) generally reflects optimism about the company's growth prospects in the expanding home and community-based healthcare market. Key valuation metrics, such as the P/E ratio of 90.1, suggest investor expectations of future earnings growth. Analysts often highlight the company's strategic focus on Medicare and Medicaid populations as a stable revenue driver.
What are the main risks for BTSG?
BrightSpring Health Services, Inc. faces several risks inherent to the healthcare industry and its specific business model. Increased competition from other healthcare providers could pressure margins and market share. Changes in government regulations, particularly those affecting Medicare and Medicaid reimbursement rates, could significantly impact revenue.
What are the key factors to evaluate for BTSG?
BrightSpring Health Services, Inc. (BTSG) holds an AI score of 83/100 (high). P/E: 90.1x vs the S&P 500's ~20-25x. Analysts target $44.47 (-25%). Not financial advice.
How frequently does BTSG data refresh on this page?
BTSG's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven BTSG's recent stock price performance?
BrightSpring Health Services, Inc. (BTSG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated home and community-based care model. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BTSG overvalued or undervalued right now?
BrightSpring Health Services, Inc. (BTSG) trades at 90.1x earnings. Analysts target $44.47 (-25%) — downside risk seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research BTSG before investing?
Before investing in BrightSpring Health Services, Inc. (BTSG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are as of the latest available reporting period.